Literature DB >> 19779031

VopF, a type III effector protein from a non-O1, non-O139 Vibrio cholerae strain, demonstrates toxicity in a Saccharomyces cerevisiae model.

Ranjana Tripathi1, Santa Singh Naorem1, Chetna Dureja1, Swati Haldar1, Alok K Mondal1, Saumya Raychaudhuri1.   

Abstract

VopF, a type III effector protein, has been identified as a contributory factor to the intestinal colonization of type III secretion system-positive, non-O1, non-O139 Vibrio cholerae strains. To gain more insight into the function of VopF, a yeast model was developed. Using this model, it was found that ectopic expression of VopF conferred toxicity in yeast.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19779031     DOI: 10.1099/jmm.0.012336-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  7 in total

1.  Identification of Vibrio cholerae type III secretion system effector proteins.

Authors:  Ashfaqul Alam; Kelly A Miller; Mudit Chaand; J Scott Butler; Michelle Dziejman
Journal:  Infect Immun       Date:  2011-01-31       Impact factor: 3.441

2.  Anaplasma phagocytophilum AptA modulates Erk1/2 signalling.

Authors:  Bindu Sukumaran; Juliana E Mastronunzio; Sukanya Narasimhan; Sarah Fankhauser; Pradeep D Uchil; Roie Levy; Morven Graham; Tonya Michelle Colpitts; Cammie F Lesser; Erol Fikrig
Journal:  Cell Microbiol       Date:  2010-08-27       Impact factor: 3.715

3.  Mechanism of actin filament nucleation by the bacterial effector VopL.

Authors:  Bingke Yu; Hui-Chun Cheng; Chad A Brautigam; Diana R Tomchick; Michael K Rosen
Journal:  Nat Struct Mol Biol       Date:  2011-08-28       Impact factor: 15.369

4.  Identification of Critical Amino Acids Conferring Lethality in VopK, a Type III Effector Protein of Vibrio cholerae: Lessons from Yeast Model System.

Authors:  Leela Krishna Bankapalli; Rahul Chandra Mishra; Balvinder Singh; Saumya Raychaudhuri
Journal:  PLoS One       Date:  2015-10-21       Impact factor: 3.240

5.  In Silico Screening of Antibacterial Compounds from Herbal Sources Against Vibrio cholerae.

Authors:  Sabah Perveen; Hotam Singh Chaudhary
Journal:  Pharmacogn Mag       Date:  2015-10       Impact factor: 1.085

6.  VopE, a Vibrio cholerae Type III Effector, Attenuates the Activation of CWI-MAPK Pathway in Yeast Model System.

Authors:  Leela K Bankapalli; Rahul C Mishra; Saumya Raychaudhuri
Journal:  Front Cell Infect Microbiol       Date:  2017-03-20       Impact factor: 5.293

Review 7.  The SPI-1-like Type III secretion system: more roles than you think.

Authors:  Frank Egan; Matthieu Barret; Fergal O'Gara
Journal:  Front Plant Sci       Date:  2014-02-12       Impact factor: 5.753

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.